LXRX
#2439
Lexicon Pharmaceuticals, Inc. - Common Stock
2.3 2 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.43%
Monthly Change
-2.52%
6 month change
+63.38%
Year Change
+105.31%
Previous Close
2.3 1
Open
2.3 2
Low
2.3 2
High
2.3 2
Volume
69
Financials
- Market Capitalization 1.03 B
- Employee 81
- Founded 1995
- CEO Lonnel Coats
- Website www.lexpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BQ85G2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.21
Price to sales ratio
8.38
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2421 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 20.05 USD | -2.43% | +0.15% | +1.88% | +112.85% | 1.08 B USD | ||
| 2428 |  CADL Candel Therapeutics, Inc. - Common Stock | 13.75 USD | +3.54% | +8.70% | +40.16% | +135.04% | 1.05 B USD | ||
| 2445 |  IMMX Immix Biopharma, Inc. - Common Stock | 14.31 USD | +1.71% | +7.03% | +68.95% | +522.17% | 1.02 B USD | ||
| 2446 |  ABUS Arbutus Biopharma Corporation - Common Stock | 5.17 USD | -0.39% | -0.58% | +17.23% | +40.49% | 1.02 B USD |
Frequently asked questions about Lexicon Pharmaceuticals, Inc.
What is the Lexicon Pharmaceuticals, Inc. stock price today?
The current price of Lexicon Pharmaceuticals, Inc. (LXRX) is 2.32. Over the past 24 hours, the stock has changed by +0.43%. Follow the LXRX chart for real-time price dynamics.
What is the stock ticker of Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. trades under the ticker LXRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lexicon Pharmaceuticals, Inc. stock going up?
LXRX has changed by +5.94% over the last week, -2.52% over the last month, and +105.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. currently has a market capitalization of 1.03 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Lexicon Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Lexicon Pharmaceuticals, Inc. reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Lexicon Pharmaceuticals, Inc. revenue for the last quarter?
Lexicon Pharmaceuticals, Inc. reported quarterly revenue of 692 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Lexicon Pharmaceuticals, Inc. net income for the last quarter?
Lexicon Pharmaceuticals, Inc. reported net income of -31.77 M for the last quarter. The previous quarter showed -1.04 M, which means net income changed by -2946.50%.
How many employees does Lexicon Pharmaceuticals, Inc. have?
As of the latest available data, Lexicon Pharmaceuticals, Inc. has 81 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lexicon Pharmaceuticals, Inc. EBITDA?
Lexicon Pharmaceuticals, Inc. EBITDA is -26.44 M, and its EBITDA margin is -3 820.52%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lexicon Pharmaceuticals, Inc. stock?
You can buy Lexicon Pharmaceuticals, Inc. (LXRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lexicon Pharmaceuticals, Inc. stock?
Investing in Lexicon Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LXRX chart and related analysis on metatrader.com as part of your research.